Back to top
more

Chemed (CHE)

(Real Time Quote from BATS)

$565.44 USD

565.44
19,913

+7.17 (1.28%)

Updated Nov 11, 2024 12:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita

DVA or CHE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

DVA vs. CHE: Which Stock Is the Better Value Option?

Nalak Das headshot

5 Safe Picks Amid Yield Inversion and Geopolitical Concerns

by Nalak Das

Throughout this month, U.S. stock markets are witnessing extreme volatility. Equities are suffering as investors are flocking to safe-haven sovereign bonds.

Nitish Marwah headshot

New Strong Buy Stocks for August 8th

by Nitish Marwah

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Buy These 5 Low Leverage Stocks to Keep Your Portfolio Secure

by Zacks Equity Research

Since existence of a debt-free company is rare, the real challenge for an investor is determining whether an organization???s debt level is sustainable.

Chemed (CHE) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Chemed (CHE) have what it takes to be a top stock pick for momentum investors? Let's find out.

Chemed (CHE) Earnings Top Estimates in Q2, Margins Expand

by Zacks Equity Research

It is encouraging to note that Chemed (CHE) witnessed solid revenue growth across both of its key subsidiaries.

Chemed (CHE) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Chemed (CHE) delivered earnings and revenue surprises of 8.74% and 0.80%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

DVA vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

DVA vs. CHE: Which Stock Is the Better Value Option?

Chemed (CHE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak

by Zacks Equity Research

Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.

Here's Why Chemed (CHE) Should Remain in Your Portfolio Now

by Zacks Equity Research

Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.

DGX vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

DGX vs. CHE: Which Stock Is the Better Value Option?

Chemed's VITAS Business Strong, Weak Acuity Mix Shifts a Woe

by Zacks Equity Research

Chemed's (CHE) VITAS registers an expanded average daily census.

Why Is Chemed (CHE) Up 1.2% Since Last Earnings Report?

by Zacks Equity Research

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DGX vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

DGX vs. CHE: Which Stock Is the Better Value Option?

Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y

by Zacks Equity Research

Despite several downsides, Chemed (CHE) witnesses solid revenue growth across key subsidiaries - VITAS and Roto-Rooter.

DGX vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

DGX vs. CHE: Which Stock Is the Better Value Option?

Here's Why You Should Invest in Chemed (CHE) Stock Right Now

by Zacks Equity Research

Chemed (CHE) is expected to benefit from the launch of its VITAS Healthcare Inpatient Hospice Unit.

Here's Why You Should Hold on to DaVita (DVA) Stock Now

by Zacks Equity Research

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.

Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

Shrabana Mukherjee headshot

These 5 Stocks Make Great Buys on New Analyst Coverage

by Shrabana Mukherjee

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Why Is Chemed (CHE) Up 2.7% Since Last Earnings Report?

by Zacks Equity Research

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).